Chambers Rebecca Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
7
Insider Sells Sum
$6.29M

Insider Activity of Chambers Rebecca

According to the SEC Form 4 filings, Chambers Rebecca, being in a position of

  1. Chief Financial Officer at Veracyte, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 45832 shares for $1.91M,
    over all time since 2024-11-12, has bought 0 shares, and sold 68634 shares for $2.82M.

Biography of Chambers Rebecca

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$1,906,3015100

Comparison of Insiders on Amount of Buys and Sells

2026-09-04SaleVeracyte, Inc.
VCYT
Chief Financial Officer
3,652
0.0046%
$43.10$157,394+4.37%
2026-06-04SaleVeracyte, Inc.
VCYT
Chief Financial Officer
3,561
0.0046%
$49.73$177,083-7.35%
2026-03-04SaleVeracyte, Inc.
VCYT
Chief Financial Officer
18,341
0.0231%
$36.14$662,869+21.42%
2025-12-04SaleVeracyte, Inc.
VCYT
Chief Financial Officer
13,278
0.0166%
$46.84$621,955-9.47%
2025-11-05SaleVeracyte, Inc.
VCYT
Chief Financial Officer
7,000
0.0101%
$41.00$287,000-6.86%
2025-02-03SaleVeracyte, Inc.
VCYT
Chief Financial Officer
527
0.0007%
$43.85$23,109-28.67%
2024-12-03SaleVeracyte, Inc.
VCYT
Chief Financial Officer
7,000
0.009%
$43.23$302,622-26.52%
2024-11-12SaleVeracyte, Inc.
VCYT
Chief Financial Officer
15,275
0.0198%
$38.34$585,663-16.11%
2021-06-24SaleOutset Medical, Inc.
OM
Chief Financial Officer
33,454
0.0409%
$28.48$952,917-14.65%
2021-05-25SaleOutset Medical, Inc.
OM
Chief Financial Officer
33,454
0.0401%
$25.68$859,079-4.67%
2021-04-27SaleOutset Medical, Inc.
OM
Chief Financial Officer
33,454
0.0718%
$56.60$1.89M-21.24%
2021-03-25SaleOutset Medical, Inc.
OM
Chief Financial Officer
33,454
0.0768%
$49.94$1.67M-9.38%
Total: 12
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.